Durosinmi MA - Search Results

1

Late presentation of chronic myeloid leukaemia patients in a low-income country: the prognostic implications and impact on treatment outcome.

Nelson EA, Ahmed IO, Bolarinwa RA, Adeagbo BA, Adegbola AJ, Salawu L, Bolaji OO, Durosinmi MA. Nelson EA, et al. Among authors: durosinmi ma. BMC Res Notes. 2024 Sep 3;17(1):245. doi: 10.1186/s13104-024-06910-9. BMC Res Notes. 2024. PMID: 39227850 Free PMC article.

2

Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia.

Adeagbo BA, Bolaji OO, Olugbade TA, Durosinmi MA, Bolarinwa RA, Masimirembwa C. Adeagbo BA, et al. Among authors: durosinmi ma. J Clin Pharm Ther. 2016 Oct;41(5):546-51. doi: 10.1111/jcpt.12424. Epub 2016 Jul 18. J Clin Pharm Ther. 2016. PMID: 27426203

3

Population Pharmacokinetics of Imatinib in Nigerians With Chronic Myeloid Leukemia: Clinical Implications for Dosing and Resistance.

Adeagbo BA, Olugbade TA, Durosinmi MA, Bolarinwa RA, Ogungbenro K, Bolaji OO. Adeagbo BA, et al. Among authors: durosinmi ma. J Clin Pharmacol. 2017 Dec;57(12):1554-1563. doi: 10.1002/jcph.953. Epub 2017 Jun 15. J Clin Pharmacol. 2017. PMID: 28618035

4

Autoimmune haemolytic anaemia: pattern of presentation and management outcome in a Nigerian population: a ten-year experience.

Salawu L, Durosinmi MA. Salawu L, et al. Among authors: durosinmi ma. Afr J Med Med Sci. 2002 Jun;31(2):97-100. Afr J Med Med Sci. 2002. PMID: 12518900

5

Immune thrombocytopaenic purpura: 11-year experience in Ile-Ife, Nigeria.

Salawu L, Durosinmi MA. Salawu L, et al. Among authors: durosinmi ma. Afr J Med Med Sci. 2001 Mar-Jun;30(1-2):99-103. Afr J Med Med Sci. 2001. PMID: 14510161

6

Clinical and prognostic features of Nigerians with chronic myeloid leukemia.

Boma PO, Durosinmi MA, Adediran IA, Akinola NO, Salawu L. Boma PO, et al. Among authors: durosinmi ma. Niger Postgrad Med J. 2006 Mar;13(1):47-52. Niger Postgrad Med J. 2006. PMID: 16633379

7

AIDS-related lymphomas in Nigeria.

Bolarinwa RA, Ndakotsu MA, Oyekunle AA, Salawu L, Akinola NO, Durosinmi MA. Bolarinwa RA, et al. Among authors: durosinmi ma. Braz J Infect Dis. 2009 Oct;13(5):359-61. doi: 10.1590/S1413-86702009000500009. Braz J Infect Dis. 2009. PMID: 20428636

8

Chronic lymphocytic leukaemia: a-twenty-years experience and problems in Ile-Ife, South-Western Nigeria.

Salawu L, Bolarinwa RA, Durosinmi MA. Salawu L, et al. Among authors: durosinmi ma. Afr Health Sci. 2010 Jun;10(2):187-92. Afr Health Sci. 2010. PMID: 21326974 Free PMC article.

9

Determinants of Overall and Progression-Free Survival of Nigerian Patients with Philadelphia-Positive Chronic Myeloid Leukemia.

Oyekunle AA, Bolarinwa RA, Oyelese AT, Salawu L, Durosinmi MA. Oyekunle AA, et al. Among authors: durosinmi ma. Adv Hematol. 2015;2015:908708. doi: 10.1155/2015/908708. Epub 2015 Sep 7. Adv Hematol. 2015. PMID: 26435715 Free PMC article.

10

Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival.

Oyekunle AA, Durosinmi MA, Bolarinwa RA, Owojuyigbe T, Salawu L, Akinola NO. Oyekunle AA, et al. Among authors: durosinmi ma. Clin Med Insights Blood Disord. 2016 Jun 20;9:9-13. doi: 10.4137/CMBD.S31562. eCollection 2016. Clin Med Insights Blood Disord. 2016. PMID: 27375361 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters